Sequence Analysis of Kaposi Sarcoma–Associated Herpesvirus (KSHV) MicroRNAs in Patients with Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sequence Analysis of Kaposi Sarcoma–Associated Herpesvirus (KSHV) MicroRNAs in Patients with Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 205, Issue 11, Pages 1665-1676
Publisher
Oxford University Press (OUP)
Online
2012-03-24
DOI
10.1093/infdis/jis249
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy
- (2011) T. S. Uldrick et al. BLOOD
- Kaposi's Sarcoma-Associated Herpesvirus ORF57 Promotes Escape of Viral and Human Interleukin-6 from MicroRNA-Mediated Suppression
- (2011) J.-G. Kang et al. JOURNAL OF VIROLOGY
- miR-K12-7-5p Encoded by Kaposi's Sarcoma-Associated Herpesvirus Stabilizes the Latent State by Targeting Viral ORF50/RTA
- (2011) Xianzhi Lin et al. PLoS One
- Role of pri-miRNA tertiary structure in miR-17~92 miRNA biogenesis
- (2011) Steven G Chaulk et al. RNA Biology
- Common genetic polymorphisms in pre-microRNAs were associated with increased risk of dilated cardiomyopathy
- (2010) Bin Zhou et al. CLINICA CHIMICA ACTA
- An Interleukin‐6–Related Systemic Inflammatory Syndrome in Patients Co‐Infected with Kaposi Sarcoma–Associated Herpesvirus and HIV but without Multicentric Castleman Disease
- (2010) Thomas S. Uldrick et al. CLINICAL INFECTIOUS DISEASES
- MicroRNAs encoded by Kaposi's sarcoma-associated herpesvirus regulate viral life cycle
- (2010) Chih-Chung Lu et al. EMBO REPORTS
- Kaposi Sarcoma (KS)–Associated Herpesvirus MicroRNA Sequence Analysis and KS Risk in a European AIDS‐KS Case Control Study
- (2010) Vickie Marshall et al. JOURNAL OF INFECTIOUS DISEASES
- Epigenetic Regulation of Kaposi's Sarcoma-Associated Herpesvirus Latency by Virus-Encoded MicroRNAs That Target Rta and the Cellular Rbl2-DNMT Pathway
- (2010) F. Lu et al. JOURNAL OF VIROLOGY
- Regulation of Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Receptor Protein (TWEAKR) Expression by Kaposi's Sarcoma-Associated Herpesvirus MicroRNA Prevents TWEAK-Induced Apoptosis and Inflammatory Cytokine Expression
- (2010) J. R. Abend et al. JOURNAL OF VIROLOGY
- Regulation of NF-κB inhibitor IκBα and viral replication by a KSHV microRNA
- (2010) Xiufen Lei et al. NATURE CELL BIOLOGY
- Small RNA profiling reveals antisense transcription throughout the KSHV genome and novel small RNAs
- (2010) Y.-T. Lin et al. RNA
- microRNA miR-196a-2 and Breast Cancer: A Genetic and Epigenetic Association Study and Functional Analysis
- (2009) A. E. Hoffman et al. CANCER RESEARCH
- Regulation of KSHV Lytic Switch Protein Expression by a Virus-Encoded MicroRNA: An Evolutionary Adaptation that Fine-Tunes Lytic Reactivation
- (2009) Priya Bellare et al. Cell Host & Microbe
- Diverse Herpesvirus MicroRNAs Target the Stress-Induced Immune Ligand MICB to Escape Recognition by Natural Killer Cells
- (2009) Daphna Nachmani et al. Cell Host & Microbe
- Pivotal Advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes
- (2009) Zhiqiang Qin et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs
- (2008) Meiqun Wu et al. CARCINOGENESIS
- Tandem array–based expression screens identify host mRNA targets of virus-encoded microRNAs
- (2008) Joseph M Ziegelbauer et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More